THU0261 Correlation between Time to Switch and Clinical Response Amplitude to Rituximab in Second Line Treatment in Rheumatoid Arthritis Patients with Treatment Failure to Tumor Necrosis Factor Inhibitors: 3-Year Data from Repeat Observational Study
Ancuta, I., Codreanu, C., Ionescu, R., Balanescu, A., Rezus, E., Suta, M., Ciurea, P., Milicescu, M., Nemes, D., Ancuta, C., Bojinca, M., Parvu, M., Popoviciu, H.Volume:
73
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2014-eular.2613
Date:
June, 2014
File:
PDF, 65 KB
english, 2014